UC
Decoding IBD: 5 Practice-Changing Lessons
Managing inflammatory bowel disease involves precise diagnosis, vigilant monitoring and strategic treatment ...
AUGUST 25, 2025
Alcohol Use Associated With UC Flares
Many patients with IBD have long attested that alcohol has harmful effects on their condition, and data from a ...
AUGUST 7, 2025
Upadacitinib Appears Safe, Effective In Older Adults With UC
Upadacitinib is safe for adults 50 years of age and older with moderate to severe UC, according to retrospective ...
JULY 29, 2025
Approach to a Patient With IBD-Associated Peripheral Spondyloarthropathies
Extraintestinal manifestations are common in patients with IBD. They usually appear during the course of IBD, but ...
JUNE 20, 2025
SubQ Guselkumab Found to Hit All Targets by 12 Weeks
Subcutaneous administration of guselkumab resulted in achievement of all study end points in people with moderate ...
JUNE 9, 2025
Risankizumab After Advanced Therapy for UC; GLP-1s for IBD
The first study in The Regueiro Report this month is a post hoc analysis of two successful phase 3 trials, INSPIRE ...
MAY 28, 2025
Low-Dose Aspirin During Pregnancy for Women With IBD, Guselkumab for Moderate to Severe UC
The first study in The Regueiro Report this month focuses on the intersection of pregnancy and inflammatory bowel ...
APRIL 24, 2025
Subcutaneous Infliximab Found Effective With or Without an Immunosuppressant
Patients who achieved a clinical response to subcutaneous infliximab showed no meaningful differences in outcomes ...
MARCH 5, 2025
Genetic Link to Severe UC Identified
In a genome-wide association study, Danish researchers found strong links between an allele on the human leukocyte ...
FEBRUARY 27, 2025
Risankizumab and Tulisokibart for Ulcerative Colitis
We rarely discuss early trials, but this month we highlight a phase 2 trial that offers a promising new mechanism ...
JANUARY 23, 2025
FDA Approves Omvoh for Moderate to Severe Crohn’s Disease
The FDA has approved mirikizumab as a first-line therapy for moderate to severe Crohn’s disease in adults.
JANUARY 17, 2025
Expert Picks From ACG 2024: Part 2
In this second installment of Expert Picks from ACG 2024, Brooks D. Cash, MD, FACG, discusses five colon- and ...
JANUARY 16, 2025
